Molecular biology and stem cell research have had an immense impact on our understanding of neurological diseases, for which little or no therapeutic options exist today. Manipulation of the underlying disease-specific molecular and cellular events promises more efficient therapy. Angiogenesis, i.e. the regrowth of new vessels from an existing vascular network, has been identified as a key contributor for the progression of tumor and, more recently, for regeneration after stroke. Donation of stem cells has proved beneficial to treat cerebral lesions. However, before angiogenesis-targeted and stem cell therapies can safely be used in patients, underlying biological processes need to be better understood in animal models. Noninvasive imaging is essential in order to follow biological processes or stem cell fate in both space and time. We optimized steady state contrast enhanced magnetic resonance imaging (SSCE MRI) to monitor vascular changes in rodent models of tumor and stroke. A modification of mathematical modeling of MR signal from the vascular network allowed for the first time simultaneous measurements of relaxation time T2 and SSCE MRI derived blood volume, vessel size, and vessel density. Limitations of SSCE MRI in tissues with high blood volume and non-cylindrically shaped vessels were explored. SSCE MRI detected angiogenesis and response to anti-angiogenic treatment in two rodent tumor models. In both tumor models, reduction of blood volume in small vessels and a shift towards larger vessels was observed upon treatment. After stroke, decreased vessel density and increased vessel size was found, which was most pronounced one week after the infarct. This is in agreement with two initial, recently published clinical studies. Overall, very little signs of angiogenesis were found. Furthermore, superparamagnetic iron oxide (SPIO) labels were used to study neural stem cells (NSCs) in vivo with MRI. SPIO labeling revealed a decrease in volume of intracerebral grafts over 4 months, assessed by T2* weighted MRI. Since SPIO labels are challenging to quantify and their MR contrast can easily be confounded, we explored the potential of in vivo 19F MRI of 19F labeled NSCs. Hardware was developed for in vitro and in vivo 19F MRI. NSCs were labeled with little effect on cell function and in vivo detection limits were determined at ~10,000 cells within 1 h imaging time. A correction for the inhomogeneous magnetic field profile of surface coils was validated in vitro and applied for both sensitive and quantitative in vivo cell imaging. As external MRI labels do not provide information on NSC function we combined 19F MRI with bioluminescence imaging (BLI). The BLI signal allowed quantification of viable cells whereas 19F MRI provided graft location and density in 3D over 4 weeks both in the healthy and stroke brain. A massive decrease in number of viable cells was detected independent of the microenvironment. This indicates that functional recovery reported in many studies of NSC implantation after stroke, is rather due to release of factors by NSCs than direct tissue replacement. In light of these indirect effects, combination of the imaging methods developed in this dissertation with other functional and structural imaging methods is suggested in order to further elucidate interactions of NSCs with the vasculature
